Cana Tablets (Calidino-genase)

Adult dose

Administer orally in 3 divided doses of 30~150I.U. per day. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients who have recently experienced a cerebral hemorrhage or have bleeding. Additionally, it contains lactose, so it should not be administered to patients with a genetic disorder that prevents the digestion of lactose. The medication contains colorant Yellow No. 5, so caution is required for those allergic or sensitive to this component. Allergic symptoms such as skin rash or itching may occur during use, and immediate discontinuation of use is necessary if such symptoms arise. Occasionally, symptoms such as palpitations, digestive discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may appear. Rarely, symptoms like fever, headache, dizziness, drowsiness, and fatigue may occur, so caution is advised. Particularly for older individuals, who may have reduced physical function, the dosage should be lowered or managed more carefully when using this medication.

• rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• epigastric pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air and moisture from entering and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness and prevent deterioration.

Appearance

It is an orange, round, enteric-coated tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle